Looking to gain a foothold in Ireland? MSD puts shuttered site up for sale

By Dan Stanton contact

- Last updated on GMT

Image: iStock/Bigandt_Photography
Image: iStock/Bigandt_Photography
Merck & Co. has put an Irish small molecule plant up for sale after ceasing production late last year.

The facility in Swords, County Dublin had been earmarked for closure back in 2013​, but a spokesman for Merck Sharp & Dohme (MSD) – known as Merck & Co. in North America – confirmed to us “production ceased at the plant in December 2016 and MSD will exit in the Summer.”

As such, the 33 acre site is now available for sale through industrial agent, JLL.

According to JLL, “the property comprises 350,000 sq ft of flexible production, laboratory, utility, distribution and office space”​ and could be “of interest to existing global pharmaceutical users seeking to gain a foothold in the Irish Market.”

MSD’s decision to shutter the site was due to a network capacity and ongoing review of its manufacturing footprint following the merger with Schering-Plough​ in 2009, the company told this publication back in 2013.

The site – which manufactured formulated products in the areas of women’s health, anesthesia and psychiatry – is one of two Irish plants divested by MSD, the other an active pharmaceutical ingredient (API) in Rathdrum, County Wicklow put up or sale in 2013.

But despite this the Big Pharma firm has said it is committed to Ireland, investing in both capacities​ and staff​ at its biologics and vaccine manufacturing sites in Carlow, Cork and Tipperary.

Related news

Related products

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers